Drug Firms Challenge Chongqing Price Reform

(Chongqing) - Health officials, patients and pharmaceutical companies in the Chongqing region have found themselves scurrying like unwilling lab rats in a test of China's new, centralized drug pricing system.

The system, designed to control costs as part of sweeping medical reforms implemented last year, has been blamed for raising drug prices by about 70 percent.